CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke

episode

Neurology® Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Transrapid, Flugtaxis, Hyperloop – Warum es neuartige Verkehrstechnik so schwer hat 28 min · 22 Sep 2026 · Das Wissen | SWR

Las 10 de Erazno, el Chokolatazo, Parodias, Nacadas y mas 1h 25m · 22 Sep 2026 · Erazno y La Chokolata El Podcast

Cross-code immorality, Lachie Neale's strike, crowd behaviour - Andrew Voss | Across the Divide! (22.09.26) 17 min · 22 Sep 2026 · Whateley

S13 EP19: It's Exhausting Having an Opinion 37 min · 22 Sep 2026 · Parenting Hell with Rob Beckett and Josh Widdicombe

Fall in Love With the Life You Have 51 min · 22 Sep 2026 · The Candace Cameron Bure Podcast

NPR News: 09-21-2026 9PM EDT 5 min · 22 Sep 2026 · NPR News Now

Report any issue

Source

Recorded29 Jan 2026

Publisherneurology.libsyn.com ↗

Handlerec:15586597

Show notes

Dr. Tesha Monteith talks with Dr. Michael Eller about the implications of CGRP therapies in migraine treatment, particularly for patients with vascular risk factors or a history of stroke. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related